Genetic and Genomic Testing in Cardiovascular Disease
Published: November 13, 2025
- The rapid advancement of genomic and precision medicine has expanded the role of genetics and genomics in the diagnosis, risk stratification, and management of cardiovascular diseases. With the decreasing cost and increasing accessibility of genetic testing, its clinical utility continues to expand, necessitating updated policies to ensure equitable access, appropriate regulatory oversight, and ethical data stewardship.
- This policy statement by the American Heart Association provides a framework addressing key policy areas for integration of genetic and genomic testing into patient care and research.
- By advocating for a multidisciplinary approach that bridges scientific innovation, clinical application, and policy development, this statement aims to optimize the benefits of genetic and genomic testing while mitigating disparities and ethical challenges in its implementation.